Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Psyence Australia Pty Ltd
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Tizona Therapeutics, Inc
Essen Biotech
A2 Biotherapeutics Inc.
University of Nebraska
Takeda
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
Centre Hospitalier Universitaire de Besancon
AstraZeneca
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
University of Colorado, Denver
A2 Biotherapeutics Inc.
Washington University School of Medicine
A2 Biotherapeutics Inc.
Genentech, Inc.
Institut Bergonié
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Columbia University
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Memorial Sloan Kettering Cancer Center
Elevation Oncology
Pfizer
University Health Network, Toronto
Universidade Federal de Pernambuco
Astellas Pharma Inc
Actuate Therapeutics Inc.
Dana-Farber Cancer Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Sydney
Cedars-Sinai Medical Center
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Barbara Ann Karmanos Cancer Institute
Canadian Cancer Trials Group
Kineta Inc.
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Exact Sciences Corporation
Imperial College London